Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
Sponsor: Bristol-Myers Squibb
Summary
The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, adult participants with severe renal impairment, and participants with end-stage renal disease.
Official title: A Phase 1, Multi-center, Single-dose, Open-label Study to Evaluate the Pharmacokinetics and Safety of Golcadomide (BMS-986369) in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
Key Details
Gender
All
Age Range
18 Years - 84 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-09-08
Completion Date
2026-12-28
Last Updated
2026-10-01
Healthy Volunteers
Yes
Conditions
Interventions
Golcadomide
Specified dose on specified days
Locations (3)
Arizona Clinical Trials - Chandler
Chandler, Arizona, United States
Panax Clinical Research
Miami Lakes, Florida, United States
Orlando Clinical Research Center OCRC
Orlando, Florida, United States